V67A Stock Overview
Manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Cosmos Health Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.72 |
| 52 Week High | US$1.36 |
| 52 Week Low | US$0.45 |
| Beta | 3.14 |
| 11 Month Change | 4.91% |
| 3 Month Change | -33.40% |
| 1 Year Change | -23.50% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -96.11% |
Recent News & Updates
Recent updates
Shareholder Returns
| V67A | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 17.9% | 0.1% | -0.02% |
| 1Y | -23.5% | 17.2% | 8.2% |
Return vs Industry: V67A underperformed the German Healthcare industry which returned 17.2% over the past year.
Return vs Market: V67A underperformed the German Market which returned 8.2% over the past year.
Price Volatility
| V67A volatility | |
|---|---|
| V67A Average Weekly Movement | 11.3% |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: V67A's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: V67A's weekly volatility has decreased from 18% to 11% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 123 | Greg Siokas | www.cosmosholdingsinc.com |
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.
Cosmos Health Inc. Fundamentals Summary
| V67A fundamental statistics | |
|---|---|
| Market cap | €15.01m |
| Earnings (TTM) | -€32.47m |
| Revenue (TTM) | €53.82m |
0.3x
P/S Ratio-0.5x
P/E RatioIs V67A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| V67A income statement (TTM) | |
|---|---|
| Revenue | US$56.04m |
| Cost of Revenue | US$51.50m |
| Gross Profit | US$4.54m |
| Other Expenses | US$38.35m |
| Earnings | -US$33.81m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.61 |
| Gross Margin | 8.10% |
| Net Profit Margin | -60.34% |
| Debt/Equity Ratio | 29.4% |
How did V67A perform over the long term?
See historical performance and comparison